1 / 18

B 12 SUPPLEMENTATION AUDIT

B 12 SUPPLEMENTATION AUDIT. Jonathan Lolljee. Justification for Audit. Many patients on hydroxocobalamin have not had an IFA test PA patients at increased risk of gastric cancer Many patients on hydroxocobalamin had a negative IFA test

britain
Download Presentation

B 12 SUPPLEMENTATION AUDIT

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. B12 SUPPLEMENTATIONAUDIT Jonathan Lolljee

  2. Justification for Audit • Many patients on hydroxocobalamin have not had an IFA test • PA patients at increased risk of gastric cancer • Many patients on hydroxocobalamin had a negative IFA test • Do ALL patients with low vit B12 need IM injections for the rest of their lives? • Should they have a choice?

  3. IM vs Oral B12 Replacement Cyanocobalamin taken 2-3 times daily Advantages of tablets NO NEEDLES! Disadvantages of tablets • More expensive • Compliance issues • Unpredictable absorption

  4. Agreed Standards No official guidance available Dr Cuthbert consulted = no concerns re. tablets All patients with low b12: 1] should undergo IFA testing 2] should be offered the option of IM or oral B12

  5. Aims of Audit • Assess if patients on hydroxocobalamin have had IFA analysis performed? • Of the patients on hydroxocobalamin who have had IFA analysis performed, how many are actually positive for this result? • Offer patients with negative IFA the option of switching to cyanocobalamin

  6. Method SystmOne search based on hydroxocobalmin - 78 results IBD excluded - IFA test no result Case-by-case manual check Audit assessment form completed for each case Exclusions criteria: - cancer, GIT Sx, CNS disease - pancreatic insufficiency - congenital b12 deficiency - Hx of gastritis

  7. Results from 1st Cycle • Included cases = 58 patients • Age range 23-92 years • Mean age 68-years old • 18 different RCs to describe b12 deficiency • IFA performed in 48% (28/58) • +ve IFA in 2/28 cases

  8. Conclusions after 1st Cycle • Many patients have an unclear dx • IFA test not routinely read-coded • Many patients could potentially be switched to cyanocobalamin

  9. Actions Taken after the 1st Cycle • Letters sent to 30 cases without IFA test • Letters sent to 26 patients re. potential a switch to oral B12 supplementation • d/w Tracy Burrell (Admin at Holycroft) • d/w Mr McGuffie (AGH Path Labs)

  10. Further Results Of the 30 patients asked to get a BT - 4 non-responders - 6 positive for IFA - 20 negative for IFA 8 / 20 cases with –ve IFA switched Of 26/28 cases with –ve IFA, 5 switched

  11. Results of Second Cycle • Included cases = 56 patients • 8 new cases • IFA performed in 54% (30/56) • +ve IFA in 3/30 cases • Only 1 of 8 new cases had no IFA

  12. Conclusions • My audit has improved management • IFA performed more frequently • More patients diagnosed with PA • Almost 1/3 eligible patients switched

  13. Worthwhile Audit? IM b12 has many advantages vs oral b12 BUT holistically & medically worthwhile

  14. Limitations of Audit • Read-coding limitations • Note-keeping • Poor search strategy • Time limitations • IFA test = sensitivity 60%

  15. Suggestions for Implementation • Annual report of patients on IM B12 • Annual report of patients with -ve IFA • Annual report of patients on oral B12

  16. SUMMARY Patients should have an IFA test if vitamin-b12 deficient Patients negative for IFA should be offered a choice of either parenteral or oral B12 replacement Cyanocobalamin may be especially useful in: - needle-phobic patients - anxious patients - patients with poor mobility (rpt script can be posted)

More Related